Search results
24 sty 2022 · Now, a study led by Stanford Medicine researchers has proved that the Epstein-Barr virus, a common type of herpes virus, triggers multiple sclerosis by priming the immune system to attack the body’s own nervous system.
The central role of Epstein-Barr virus in causing multiple sclerosis is examined to understand how it triggers the disease and presents new opportunities for treatment.
21 mar 2023 · Emergence of a definitive link between Epstein–Barr virus (EBV) and multiple sclerosis has provided an impetus to develop immune‐based therapies to target EBV‐infected B cells.
9 kwi 2024 · A team of researchers developed a new blood test to measure the immune response to the Epstein Barr Virus, which is the leading risk factor for developing multiple sclerosis.
11 mar 2022 · Epstein-Barr virus (EBV) is a putative trigger for multiple sclerosis (MS). Bjornevik et al. utilized longitudinal analysis of 10 million adults to strongly link MS to EBV infection1 and Lanz et al. identified clonally expanded B cells in MS that bind EBV EBNA1 and GlialCam.2
9 lut 2023 · In the first approach, monoclonal antibodies (mAbs) to CD20 are used to kill B cells that harbour latent EBV infection; such mAbs have been approved to treat patients with MS. Targeting of mAbs...
5 sie 2022 · We consider how knowledge of EBV-associated cancers may be instructive for understanding the role of EBV in MS and discuss the potential for therapies that target EBV to treat MS....
